Professional Marketing briefs: December 2012

Share this article:
Novartis announces good heart drug results
Novartis announces good heart drug results

Eli Lilly is expanding its Indiana insulin manufacturing operations, marking the first expansion of the company's Indianapolis sites in more than twenty years. The company noted in a statement that the new capacity is to meet US demand.

Novartis continues to focus on making Singapore its biotech and manufacturing hub. The company announced October 31 that it was investing more than $500 million in building a manufacturing facility that will focus on drugs based on cell culture technology. The company said in a statement it expects work to wrap by 2016.

Fallout from Johnson & Johnson's disappointing Alzheimer's drug trials continue to pile up. The company is now laying off 130 employees from the San Francisco office of its Janssen Alzheimer's Immunotherapy unit, reported Pharmalot. Bapineuzumab was a joint effort that included Johnson & Johnson, Pfizer and Elan.

Pfizer is laying off 300 employees in Canada, the Canadian Broadcast Wire reported October 28. The layoffs will shrink Pfizer's northern footprint from 2,700 employees to 2,400. Most of the cuts will be at the Montreal-area headquarters.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Agency Gallery

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters